This site is intended for healthcare professionals only
In association with the Cardiorenal Forum
Latest Article
SGLT2 inhibitors versus GLP-1 receptor agonists for renal patients: does it matter?
In the last ten years, the advent of sodium–glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has been s...